Emerging role of microRNAs in liver diseases

Bala, Shashi; Marcos, Miguel; Szabo, Gyongyi
December 2009
World Journal of Gastroenterology;12/7/2009, Vol. 15 Issue 45, p5633
Academic Journal
MicroRNAs are a class of small non-coding RNAs that are found in plants, animals, and some viruses. They modulate the gene function at the post-transcriptional level and act as a fine tuner of various processes, such as development, proliferation, cell signaling, and apoptosis. They are associated with different types and stages of cancer. Recent studies have shown the involvement of microRNAs in liver diseases caused by various factors, such as Hepatitis C, Hepatitis B, metabolic disorders, and by drug abuse. This review highlights the role of microRNAs in liver diseases and their potential use as therapeutic molecules.


Related Articles

  • A New Strategy for Treatment of Liver Fibrosis. Chen, Shao-Long; Zheng, Ming-Hua; Shi, Ke-Qing; Yang, Tao; Chen, Yong-Ping // BioDrugs;2013, Vol. 27 Issue 1, p25 

    MicroRNAs (miRNAs) are short, endogenous, noncoding RNA molecules that regulate gene expression at a post-translational level. MiRNAs have been recognized in the regulation of physiological conditions. Moreover, awareness of the association between dysregulated miRNAs and human diseases is...

  • Continuing Outbreak of Hepatitis A Linked with Intravenous Drug Abuse in Multnomah County. Schade, Charles P.; Komorwska, Danuta // Public Health Reports;Sep/Oct88, Vol. 103 Issue 5, p452 

    A communitywide outbreak of hepatitis A occurred in Portland, OR, from 1983 through 1986. At the peak of the outbreak, the age- and sex-specific annual incidence rate approached 400 cases per 100,000 population among men ages 25 to 34, the highest risk group. The community incidence rate was...

  • Structural features of small RNA precursors determine Argonaute loading in Caenorhabditis elegans. Steiner, Florian A.; Hoogstrate, Suzanne W.; Okihara, Kristy L.; Thijssen, Karen L.; Ketting, Rene F.; Plasterk, Ronald H. A.; Sijen, Titia // Nature Structural & Molecular Biology;Oct2007, Vol. 14 Issue 10, p927 

    In C. elegans, DCR-1 is required for the maturation of both short interfering RNAs (siRNAs) and microRNAs (miRNAs), which are subsequently loaded into different Argonaute proteins to mediate silencing via distinct mechanisms. We used in vivo analyses to show that precursors of small RNAs contain...

  • Impairment of Metabolic Function in Chronic Hepatitis C Is Related to Factors Associated With Resistance to Therapy. Jorquera, F.; Almar, M.; Díaz-Golpe, V.; Olcóz, J. L.; García-Fernández, A.; Gonz´lez-Gallego, J. // American Journal of Gastroenterology;Aug2001, Vol. 96 Issue 8, p2456 

    OBJECTIVE: Liver disease causes a loss of hepatic function, and remission is associated with improved functional hepatic mass. The object of the present study was to investigate whether liver metabolic function assessed by antipyrine clearance is related to other disease characteristics...

  • The role of lifestyle changes in the management of chronic liver disease. Nobili, Valerio; Carter-Kent, Christine; Feldstein, Ariel E. // BMC Medicine;2011, Vol. 9 Issue 1, p70 

    The prevalence of obesity worldwide has dramatically increased during the last three decades. With obesity comes a variety of adverse health outcomes which are grouped under the umbrella of metabolic syndrome. The liver in particular seems to be significantly impacted by fat deposition in the...

  • Perceptions of drug users regarding Hepatitis C screening and care: a qualitative study. Jordan, Ashly E.; Masson, Carmen L.; Mateu-Gelabert, Pedro; McKnight, Courtney; Pepper, Nicole; Bouche, Katie; Guzman, Laura; Kletter, Evan; Seewald, Randy M.; Des-Jarlais, Don C.; Sorensen, James L.; Perlman, David C. // Harm Reduction Journal;2013, Vol. 10 Issue 1, p1 

    Background: Illicit drug users have a high prevalence of HCV and represent the majority of newly infected persons in the U.S. Despite the availability of effective HCV treatment, few drug users have been evaluated or treated for HCV. Racial and ethnic minorities have a higher incidence and...

  • Role of microRNAs in diabetes and its cardiovascular complications. Shantikumar, Saran; Caporali, Andrea; Emanueli, Costanza // Cardiovascular Research;Mar2012, Vol. 93 Issue 4, p583 

    Diabetes is the most common metabolic disorder and is recognized as one of the most important health threats of our time. MicroRNAs (miRNAs) are a novel group of non-coding small RNAs that have been implicated in a variety of physiological processes, including glucose homeostasis. Recent...

  • Invited review: decoding the microRNA response to hypoxia. Pocock, Roger // Pflugers Archiv European Journal of Physiology;Mar2011, Vol. 461 Issue 3, p307 

    microRNAs (miRNAs) were discovered nearly two decades ago by researchers who sought to understand how basic developmental mechanisms work in the nematode Caenorhabditis elegans. Since the identification of conserved miRNA families in higher eukaryotes, there has been an explosion of interest...

  • Active hepatitis C infection and HCV genotypes prevalent among the IDUs of Khyber Pakhtunkhwa. Rehman, Latif ur; Ullah, Ihasn; Ali, Ijaz; Khan, Imtiaz Ali; Iqbal, Aqib; Khan, Sanaullah; Khan, Sher Hayat; Uz Zaman, Khaleeq; Khan, Najib ullah; Swati, Zahoor Ahmed; Jahangiri, Anila Tariq // Virology Journal;2011, Vol. 8 Issue 1, p327 

    Injection drug users (IDUs) are considered as a high risk group to develop hepatitis C due to needle sharing. In this study we have examined 200 injection drug users from various regions of the Khyber Pakhtunkhwa province for the prevalence of active HCV infection and HCV genotypes by...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics